NUTX
NasdaqNUTEX HEALTH INC.
Technology · Services-Business Services, Nec
Research view
Fundamentals · SEC EDGAR · FY 2025-12-31
Revenue & Earnings — fiscal year
🔒 price chart needs market-data feed$331.5M
2021
$219.3M
2022
$247.6M
2023
$479.9M
2024
$875.3M
2025
Snapshot
SEC EDGAR · FY 2025-12-31Revenue$875.3M
Net Income$180.4M
Gross Profit$444.3M
Oper Income$275.6M
EPS (dil)$10.48
Rev/sh$127.19
FCF/sh$35.69
Book/sh$61.53
Gross M50.8%
Oper M31.5%
Profit M20.6%
FCF M28.1%
ROE42.6%
ROA19.6%
ROIC72.5%
R&D/Rev0.0%
Rev Y/Y82.4%
Rev 3Y CAGR58.6%
EPS Y/Y8.2%
EPS 3Y CAGR—
FCF 3Y CAGR89.7%
Payout—
Div/sh—
Shs Chg Y/Y+23%
Current Ratio3.41
Quick Ratio3.39
Debt/Eq0.10
Int Coverage12.4×
Net Debt$143.4M cash
Total Debt$42.5M
Cash & Eq$185.9M
Total Assets$918.5M
Oper CF$248.1M
Capex$2.5M
Free CF$245.6M
Buybacks$5.0M
Equity$423.4M
Liabilities$495.1M
Shs Outstand0.01B
SectorTechnology
🔒 P/E—
🔒 Fwd P/E—
🔒 P/S—
🔒 P/B—
🔒 Market Cap—
🔒 Div Yield—
🔒 52W Range—
🔒 Beta—
40+ fundamentals — free from SEC EDGAR (public domain). Only the 🔒 price-derived column needs a market-data feed.
Financials — annual
SEC EDGAR · last 5 FY| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $331.5M | $219.3M | $247.6M | $479.9M | $875.3M |
| Gross Profit | $179.3M | $15.4M | $34.8M | $196.3M | $444.3M |
| Operating Income | $170.3M | $-406.6M | $-31.8M | $130.7M | $275.6M |
| Net Income | $168.5M | $-432.7M | $-43.4M | $94.8M | $180.4M |
| Diluted EPS | $0.22 | $-100.36 | $-10.39 | $9.69 | $10.48 |
| Operating Cash Flow | $173.4M | $50.6M | $1.3M | $23.2M | $248.1M |
| Free Cash Flow | $136.5M | $36.0M | $-8.2M | $20.8M | $245.6M |
COMMUNITY · $NUTX0 theses
POST YOUR TAKE →Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.